Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA459695
Max Phase: Preclinical
Molecular Formula: C13H8O4
Molecular Weight: 228.20
Molecule Type: Small molecule
Associated Items:
ID: ALA459695
Max Phase: Preclinical
Molecular Formula: C13H8O4
Molecular Weight: 228.20
Molecule Type: Small molecule
Associated Items:
Synonyms (1): 1,6-Dihydroxyxanthone
Synonyms from Alternative Forms(1):
Canonical SMILES: O=c1c2ccc(O)cc2oc2cccc(O)c12
Standard InChI: InChI=1S/C13H8O4/c14-7-4-5-8-11(6-7)17-10-3-1-2-9(15)12(10)13(8)16/h1-6,14-15H
Standard InChI Key: IUSXGFFUHTXSRD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: Yes | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 228.20 | Molecular Weight (Monoisotopic): 228.0423 | AlogP: 2.36 | #Rotatable Bonds: 0 |
Polar Surface Area: 70.67 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.40 | CX Basic pKa: | CX LogP: 3.00 | CX LogD: 2.69 |
Aromatic Rings: 3 | Heavy Atoms: 17 | QED Weighted: 0.58 | Np Likeness Score: 1.18 |
1. Liu Y, Ke Z, Cui J, Chen WH, Ma L, Wang B.. (2008) Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors., 16 (15): [PMID:18632275] [10.1016/j.bmc.2008.06.043] |
2. Verbanac D, Jain SC, Jain N, Chand M, Cipčić Paljetak H, Matijašić M, Perić M, Stepanić V, Saso L.. (2012) An efficient and convenient microwave-assisted chemical synthesis of (thio)xanthones with additional in vitro and in silico characterization., 20 (10): [PMID:22537683] [10.1016/j.bmc.2012.03.074] |
3. Shi TX, Wang S, Zeng KW, Tu PF, Jiang Y.. (2013) Inhibitory constituents from the aerial parts of Polygala tenuifolia on LPS-induced NO production in BV2 microglia cells., 23 (21): [PMID:24042007] [10.1016/j.bmcl.2013.08.085] |
4. Dibwe DF, Awale S, Kadota S, Morita H, Tezuka Y.. (2013) Heptaoxygenated xanthones as anti-austerity agents from Securidaca longepedunculata., 21 (24): [PMID:24216090] [10.1016/j.bmc.2013.10.027] |
5. Klein-Júnior LC, Corrêa R, Vander Heyden Y, Cechinel Filho V.. (2019) All that glitters is not gold: Panning cytotoxic natural products and derivatives with a fused tricyclic backbone by the estimation of their leadlikeness for cancer treatment., 166 [PMID:30684866] [10.1016/j.ejmech.2019.01.028] |
6. Dean B, Cooper G, Shivkumar M, Snape TJ.. (2023) Hydroxy-xanthones as promising antiviral agents: Synthesis and biological evaluation against human coronavirus OC43., 84 [PMID:36863494] [10.1016/j.bmcl.2023.129211] |
Source(1):